
New drug for Parkinson’s shown to be effective in clinical trials: 'Very encouraged'
Fox News
A new drug is showing promise in treating Parkinson’s while reducing unwanted side effects. The pill, tavapadon, extended symptom relief without the adverse effects of the first line of treatment.
Until now, levodopa has been the standard first-line treatment for Parkinson’s patients. "Regardless of when it’s used, whether in the very beginning or as an adjunctive therapy to levodopa, we think it’s a gain overall." Recent research has found that Parkinson's cases are expected to surge by 2050, affecting up to 25 million people globally. Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
Levodopa — which is converted into dopamine in the brain and targets the D2/D3/D4 dopamine receptors — has been linked to side effects including sleep disorders, hallucinations, impulse control behavioral disorders, weight gain, leg swelling and blood pressure changes, according to the researchers.